Effect of bortezomib given alone or in combination with other agents in patients with relapsed mantle cell lymphoma

Trial Profile

Effect of bortezomib given alone or in combination with other agents in patients with relapsed mantle cell lymphoma

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2015

At a glance

  • Drugs Bortezomib (Primary) ; Bendamustine; Cyclophosphamide; Dexamethasone; Idelalisib; Lenalidomide; Rituximab
  • Indications Mantle-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top